Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Design and Synthesis of P… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Design and Synthesis of Potential Aminoacyl-tRNA Synthetase Inhibitors

Doktorsavhandling
Författare Itedale Namro Redwan
Datum för examination 2012-05-11
Opponent at public defense Dr. Ramon Eritja, Institute for Research in Biomedicine, Barcelona, Spain
ISBN 978-91-628-8445-1
Publiceringsår 2012
Publicerad vid Institutionen för kemi och molekylärbiologi
Språk en
Länkar hdl.handle.net/2077/28794
Ämnesord Aminoacyl tRNA synthetases, Aminoacyl-AMP, Bioisosteres, Amino Acids, Solution-Phase, Protective Groups, Solid-Phase Chemistry, Molecular Modelling, Biological Evaluation
Ämneskategorier Kemi

Sammanfattning

Aminoacyl-tRNA synthetases (aaRSs) are essential enzymes present in all living organisms, their catalytic activity is involved in the translation of the genetic code into functional proteins and they are potential targets for anti-infective agents. The first step in the biosynthetic pathway catalysed by aaRSs consists of activation of the corresponding amino acid by the reaction with ATP to form an aminoacyl-adenylate (aa-AMP), the key intermediate in the biosynthesis of proteins. As a result stable, analogues of aa-AMP have been identified as potential and valuable lead compounds for the development of potential aaRS inhibitors. This thesis describes the design and synthesis of potential aaRSs inhibitors. The studies involve the development of a novel solution-phase synthetic route to non-hydrolysable sulfamoyl-based aa-AMP analogues. Synthesis includes the development of a protective group strategy that utilises global deprotection under neutral conditions to minimise by-product formation. Optimal reaction conditions for the coupling of different amino acids to the sulfamoyl moiety have also been investigated. A solid-phase synthetic route leading to non-hydrolysable sulfamoyl-based aa-AMP analogues has also been developed. The novel synthetic route enables the possibility for rapid parallel synthesis of structurally diverse compounds in quantities sufficient for biological evaluation. Molecular modelling techniques have been used to gain understanding about the structure–activity relationship of the inhibitors of aaRSs based on non-hydrolysable aa-AMP analogues. A model ligand adopting the putative bioactive conformation was identified based on X-ray data and conformational searches. Novel phosphate bioisosteres of aa-AMP have been designed using the derived model. Molecular docking techniques were used for the design of ribose-free purine-based aa-AMP bioisosteres. The designed compounds were synthesised and evaluated biologically in an assay using aaRS isolated from Escherichia coli. A novel mild method for the activation and recycling of a tritylated solid-phase resin has also been developed. Recycling of recovered resin after the completion of a reaction is considered beneficial since it minimises the associated costs and is environmentally friendly. The method was used for the attachment of primary and secondary alcohols, halogen-containing alcohols and anilines to trityl resin.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?

Denna text är utskriven från följande webbsida:
http://www.gu.se/forskning/publikation/?publicationId=157156
Utskriftsdatum: 2019-08-21